Search results :

Vigabatrin

More information: STITCH, PubChem and possibly Wikipedia

ATC Code: N03AG04

Side effects

Options: Show MedDRA Preferred Terms

Side effect Data for drug Placebo Labels
1 2 3 4
Otitis media 6% - 44% 2% x
Headache common, 26% - 33% 31% x x x x
Dizziness common, 24% - 26% 17% x x x x
Viral infection 19% - 20% x x
Fatigue very common, 9% - 40% 4% - 16% x x x x
Somnolence very common, 6% - 26% 2% - 13% x x x x
Irritability common, 7% - 23% 7% x x x
Diarrhoea 6% - 16% 2% - 7% x x
Pneumonia 11% - 13% x
Nasopharyngitis 9% - 14% 10% x
Coordination abnormal 7% - 16% 2% x x
Insomnia 10% - 12% x x
Ear infection 7% - 14% x
Pharyngolaryngeal pain 7% - 14% 5% x
Tremor common, 6% - 16% 0% - 8% x x x x
Arthralgia very common, 5% - 10% 3% x x x x
Depression 6% - 14% 3% x x x
Upper respiratory tract infection 7% - 51% 4% - 6% x x
Nystagmus common, 5% - 19% 2% - 9% x x x x
Vomiting common, 7% - 20% 6% x x x x
Vision blurred common, 3% - 16% 0% - 5% x x x
Gait disturbance 6% - 12% 7% x x
Nasal congestion 4% - 13% x
Constipation 3% - 14% 2% - 3% x x
Decreased appetite 7% - 9% x
Scotoma postmarketing, very common x x x x
Body temperature increased postmarketing, 4% - 29% 3% x x
Sinusitis 5% - 9% x x
Memory impairment common, 7% - 16% 3% x x x x
Asthenia 5% - 7% 1% x x
Diplopia common, 5% - 16% 0% - 3% x x x x
Lethargy 4% - 7% 2% x
Oedema peripheral 5% - 7% 1% x
Weight increased common, 3% - 17% 2% - 3% x x x x
Back pain 4% - 7% 2% x x
Sensory disturbance 4% - 7% 2% x
Candida infection 3% - 8% x
Cough 2% - 14% 7% x x
Viral diarrhoea 5% - 6% x
Aggression common, 5% 0% x x x x
Anaemia common x x x
Dysmenorrhoea 3% - 9% 0% - 3% x x
Oedema common x x x x
Rash uncommon, 4% - 11% 4% x x x x
Influenza 3% - 7% 2% - 4% x
Nausea common, 2% - 10% 8% x x x x
Nervousness common, 2% - 5% 2% x x x x
Paraesthesia common, 2% - 7% 1% x x x x
Speech disorder common x x x
Strabismus 5% x
Urinary tract infection 4% - 6% 0% x x
Paranoid reaction common x x
Abdominal pain upper 3% - 5% 0% - 1% x
Disturbance in attention common, 0% - 9% 1% x x x
Abnormal behaviour 3% - 6% 1% - 2% x
Thinking abnormal common, 3% - 7% 0% x x x x
Mental disability common x x
Muscle twitching 1% - 9% 1% x
Dyspepsia 4% - 5% 3% x x
Hypoaesthesia 4% - 5% 1% x x
Agitation postmarketing — 4% 2% x x x x
Hyporeflexia 4% - 5% 1% x x
Confusional state postmarketing, 4% - 14% 1% x x x x
Contusion 3% - 5% 2% x
Hypotonia postmarketing, 4% - 6% x x
Pain in extremity 2% - 6% 4% x
Convulsion postmarketing, 4% - 7% x x x x
Sinus headache 2% - 6% 1% x
Status epilepticus postmarketing, 2% - 6% 0% x x x x
Myalgia 3% - 5% 1% x
Disorientation 4% 0% x
Expressive language disorder 1% - 7% 1% x
Conjunctivitis 2% - 5% x
Toothache 2% - 5% 2% x
Vertigo 2% - 5% 1% x x
Chest pain 1% - 5% 1% x x
Increased appetite 1% - 5% 1% x x
Abnormal dreams 1% - 5% 1% x
Croup infectious 1% - 5% x
Abdominal pain common, 2% - 3% 1% x x x x
Hyperreflexia 2% - 4% 3% x
Upset stomach 2% - 4% 1% x
Acne 3% 0% x
Bronchitis 0% - 5% 1% x
Eye pain 0% - 5% 0% x x
Malaise 0% - 5% 0% x
Pulmonary congestion 0% - 5% 1% x
Erectile dysfunction 0% - 5% 0% x
Sensory loss 0% - 5% 0% x
Depressed mood 0% - 5% 1% x
Anxiety 0% - 4% 3% x x
Asthenopia 2% 0% x
Dysarthria 2% 1% x
Muscle spasms 0% - 3% 1% x
Muscle strain 1% - 2% 1% x
Joint sprain 1% - 2% 1% x
Abdominal distension 0% - 2% 1% x
Thirst 0% - 2% 0% x
Tinnitus 0% - 2% 1% x
Postictal state 0% - 2% 1% x
Wound secretion 0% - 2% 0% x
Ataxia uncommon x x x
Mania uncommon x x x
Psychotic disorder postmarketing, uncommon x x x x
Hypomania postmarketing, uncommon x x x x
Congenital anomaly postmarketing x
Angioedema postmarketing, rare x x x x
Mental disorder postmarketing x x x
Cholestasis postmarketing x
Deafness postmarketing x
Delirium postmarketing x
Dyskinesia postmarketing x x
Ear disorder postmarketing x
Endocrine disorder postmarketing x
Toxic epidermal necrolysis postmarketing x
Myoclonic epilepsy postmarketing x
Oesophagitis postmarketing x
Gastrointestinal disorder postmarketing x x x
Gastrointestinal haemorrhage postmarketing x
Hamartoma postmarketing x
Hypersensitivity postmarketing x
Laryngeal oedema postmarketing x
Congenital oral malformation postmarketing x
Multi-organ failure postmarketing x
Hypertonia postmarketing x x x
Muscle spasticity postmarketing x
Myoclonus postmarketing x x x x
Nervous system disorder postmarketing x x x
Optic neuritis very rare, postmarketing x x x x
Pallor postmarketing x
Pruritus postmarketing x
Delayed puberty postmarketing x
Pulmonary embolism postmarketing x
Retinal disorder rare x x
Retinitis postmarketing x
Stevens-Johnson syndrome postmarketing x
Stridor postmarketing x
Suicide attempt rare x x x
Urticaria postmarketing, rare x x x
Encephalopathy postmarketing, rare x x x
Stupor postmarketing x x x
Apathy postmarketing x
Dentofacial anomaly postmarketing x
Congenital genital malformation postmarketing x
Unspecified disorder of skin and subcutaneous tissue postmarketing, common x x x
Limb malformation postmarketing x
Haemangioma congenital postmarketing x
Low set ears postmarketing x
Limb reduction defect postmarketing x
Supernumerary nipple postmarketing x
Congenital hydronephrosis postmarketing x
Hepatobiliary disease postmarketing x
Acute psychosis postmarketing x
Rash maculo-papular postmarketing x
Developmental delay postmarketing x
Congenital vesicoureteric reflux postmarketing x
Retinal atrophy postmarketing, rare x x x
Face oedema postmarketing x
Wave slowing postmarketing x x x
Respiratory failure postmarketing x
Talipes postmarketing x
Hip dysplasia postmarketing x
Renal aplasia postmarketing x
Dysmorphism postmarketing x
Foetal anticonvulsant syndrome postmarketing x
Hallucination very rare, postmarketing x x x
Optic atrophy very rare, postmarketing x x x
Amnesia x
Breast disorder x
Infection x
Connective tissue disorder x x
Developmental coordination disorder x
Drowsiness x
Ear pain x
Eye disorder x x x
Arthropathy x
Menstrual disorder x
Movement disorder x x
Musculoskeletal disorder x
Pain x
Neuropathy peripheral x
Personality disorder x
Purpura x
Salivary hypersecretion x
Skin disorder x
Tooth disorder x
Mood swings x
Malnutrition x
Neurotoxicity x
Visual field constriction x x
Cerebration impaired x x x
Otitis media acute x
Atrophy x x
Hyperkinesia x
Forgetfulness x
Throat irritation x
Infestation NOS x
Blood and lymphatic system disorders x x
Aggressive reaction x
Suicidal behaviour x
Cytotoxic oedema x x
Abnormal vision x

Indications

Information about indications was extracted from the indications and usage sections of the labels.

Vigabatrin / SABRIL TABLETS / SABRIL SACHETS 500 MG

Side effects:61
Source:medicines.org.au

SABRIL TABLETS / Sabril, Film coated tablet

Side effects:62
Source:Medsafe

VIGABATRIN / SABRIL TAB 500MG

Side effects:83
Source:Health Canada

VIGABATRIN

Side effects:162
Source:FDA Structured Product Label

Color scheme:

standard – alternative

    100%
    75%
    50%
    10%
    frequent (1% to 100%)
    infrequent (0.1% to 1%)
    rare (<0.1%)
    postmarketing
    0%
    no frequency information
    not found on label